4 February 2020 - The global Extracorporeal
Membrane Oxygenation (ECMO) Market
size was valued at USD 246.5 million in 2016 and is expected to grow at CAGR of
4.3% over the forecast period. The major factors boosting growth are the rising
incidences of Chronic Obstructive Pulmonary Disorder (COPD), and surging
prevalence of cardiopulmonary diseases and respiratory failures.
According
to data recorded by the American Lung Association (ALA), in 2013, COPD was
recorded to be the third largest cause of death across the U.S. In addition,
over 24.0 million individuals are estimated to remain undiagnosed in the U.S.
and 11.0 million diagnosed for COPD.
Also,
the increasing adoption of unhealthy lifestyles, such as rise in the total
tobacco consumption level among both, females and males and further development
of lifestyle disorders are augmenting the incidence rate of COPD. ECMO machines
are gaining popularity in the hospital and healthcare systems due to the rising
trend of its application during cases of respiratory disorders.
The
ECMO machines are used in cases of cardiac failure to facilitate auxiliary
oxygen support system. These machines are frequently used in patients suffering
from respiratory conditions and also in neonates and pediatric patients. The
estimated growth of these machines can be attributed to the critical nature of
the target population consisting of neonates and pediatric patients.
Modality Insights
The
segmentation of the key modalities is done on the basis of the different setups
that are provided by the ECMO circuit such as arterio-venous, veno-arterial and
veno-venous. They are used to provide hemodynamic support and to facilitate
gaseous exchange in patients with cardiac or respiratory failure.
Both
gas exchange support and hemodynamic support is provided by the veno-arterial
ECMO system. It majorly works by passing the blood flow from the patients’
heart and lungs to the ECMO circuit. The veno-venous ECMO system on the other
hand facilitates sole gas exchange support in which the blood is made to return
to the heart prior to pulmonary circulation. According to the U.S. National
Institute of Health (NIH), combination of veno-venous and veno-arterial is used
in specific cases such as cardiogenic shock.
Applications Insights
As
per applications, the market is segmented into Extracorporeal Cardiopulmonary
Resuscitation (ECPR), respiratory and cardiac. The segments are further
segmented on the basis of who is using the set up into adult application,
neonate and pediatric. The segment dominating the market in 2015 with about
40.0% of the industry share is respiratory based ECMO.
The
increasing demand for the ECMO systems is majorly attributed to rising number
of patients with chronic respiratory conditions like COPD, emphysema and
chronic bronchitis combined with a trend of growing awareness about health
disorders. As per the U.S. National Center for Health Statistics, more than 8.7
million individuals suffered from chronic bronchitis and 3.4 million
individuals suffered from emphysema in the year 2014.
Regional Insights
The
major regions in this market are North America, Europe, Asia Pacific, Latin
America and MEA. North America has grown considerably in this segment majorly
attributed to the well developed primary, secondary and tertiary care hospitals
combined with the reimbursement network, increasing awareness about the ECMO
system facilitating their rapid adoption in the hospitals and favorable
government funding.
Refinements
in the technology presently in use was made by Terumo Cardiovascular Systems
Corporation during the production of CAPIOX FX Oxygenator. This system is
expected tohelp in increasing the blood rate and offer complete control over
the entire process.
Competitive Market Share Insights
Some
key players operating in the ECMO market include MAQUET Holding B. V. & Co.
KG, Microport Scientific Corporation, Medos Medizintechnik AG, Sorin Group,
Medtronic, Plc., Terumo Cardiovascular Systems Corporation, and Nipro Medical
Corporation. The major strategic initiatives adopted by the companies in this
vertical are technological advancements in the existing portfolio and new
product development.
For
example, Medtronic Plc designed Minimax Plus Oxygen System for patients from
wide ranging age groups such as from neonates to children, with features such
as venous air director and low arterial port, which are integrated in the
system to increase the safety levels and performance.
Market Segment:
Modality Outlook (Revenue, USD Million,
2013 - 2024)
•
Veno-Arterial
• Veno-Venous
• Arterio-Venous
Application Outlook (Revenue, USD
Million, 2013 - 2024)
• Respiratory
• Neonates
• Pediatric
• Adult
• Cardiac
• Neonates
• Pediatric
• Adult
• Extracorporeal Cardiopulmonary
Resuscitation (ECPR)
• Neonates
• Pediatric
• Adult
Regional Outlook (Revenue, USD Million,
2013 - 2024)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
Comments
Post a Comment